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Sulforaphanea b s t r a c t
Sulforaphane (SFN), an activator of nuclear factor E2-related factor 2 (Nrf2), has been reported to
induce autophagy in several cells. However, little is known about its signaling mechanism of auto-
phagic induction. Here, we provide evidence that SFN induces autophagy with increased levels of
LC3-II through extracellular signal-regulated kinase (ERK) activation in neuronal cells. Pretreatment
with NAC (N-acetyl-L-cysteine), a well-known antioxidant, completely blocked the SFN-induced
increase in LC3-II levels and activation of ERK. Knockdown or overexpression of Nrf2 did not affect
autophagy. Together, the results suggest that SFN-mediated generation of reactive oxygen species
(ROS) induces autophagy via ERK activation, independent of Nrf2 activity in neuronal cells.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Sulforaphane (1-isothiocyanoate-4-[methylsulﬁnyl]-butane,
SFN) is an organic isothiocyanate that is formed from glucorapha-
nin, by myrosinase when certain cruciferous vegetables are dam-
aged (or chewed) allowing the enzyme to mix with its substrate
[1]. SFN is a potent inducer of the phase II antioxidant enzymes
such as glutathione transferase, heme oxygenase-1 (HO-1) and
NAD(P)H:quinine reductase [2,3]. The expression of the phase II
enzymes is under the control of antioxidant response element
(ARE) in their promoter regions. The activation of AREs is
modulated by nuclear factor E2-related factor 2 (Nrf2). Nrf2 issequestrated by its cytoplasmic partner, Kelch-like ECH-associated
protein 1 (Keap1), which promotes its ubiquitination and degrada-
tion through the proteasome [4,5]. Modiﬁcation of two crucial cys-
teine residues (C273 and C288) on Keap1 protein by oxidation,
alkylation or arylation stemming from oxidative stress results in
dissociation of the Nrf2/Keap1 complex. Nrf2 dissociated moves
into the nucleus and binds to ARE sequences, thus increasing the
transcription of the phase II antioxidant enzymes as well as other
Nrf2-responsive genes [5,6]. SFN was reported to block Nrf2 ubiq-
uitination by altering Keap1 conformation via the reaction with
thiols of Keap1 cysteines [7]. In addition to the induction of the
phase II detoxifying enzymes, SFN activates heat shock response
and enhances proteasome activity through the induction of heat
shock protein 27 (HSP27) expression [8], and reduces the lipopoly-
saccharide-induced secretion of pro-inﬂammatory cytokines
[9,10]. Also, SFN induces cell cycle arrest and apoptosis in many
types of cancer cells, thus inhibiting tumor growth in vivo [11,12].
Autophagy is an evolutionally conserved pathway involved in
the organized elimination of proteins, organelles and invading
microbes by lysosomes. The autophagic process starts with
the formation of an autophagosome, which enclosed within a
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autophagosomes fuse with lysosomes to generate autolysosomes,
where cytoplasmic molecules and organelles are degraded by pro-
tein hydrolyases, including cathepsin D, and recycled [13,14]. Since
altered or damaged proteins and organelles cannot be reduced by
cell division in differentiated neurons, autophagy is essential for
cellular quality control in neurons. Thus, dysfunction of autophagy
has been implicated in a number of neurodegenerative diseases,
Alzheimer’s disease (AD), Parkinson’s disease (PD) and Hunting-
ton’s disease (HD) [15,16].
Reactive oxygen species (ROS) play crucial roles as signaling
messengers in cell survival, death and immunity under physiolog-
ical conditions [17]. ROS can also act as signals for the activation of
autophagy [18–21]. SFN has been known to mediate antioxidative
and antiproliferative response as well as cell death via generating
ROS in epithelial or cancer cells [22–24]. A recent study suggested
that SFN-induced ROS play a crucial role in inducing autophagy in
pancreatic cancer cells [25]. Administration of SFN enhances auto-
phagic activity in neurons [26] and brain [27]. Although the study
revealed that SFN activates autophagy, little is known about the
signal mechanism of their action, especially in neuronal cells.
In present study, we provide evidences that SFN induces
autophagy via ROS-mediated extracellular signal-regulated kinase
(ERK) activation in neuronal cells, and it is independent of Nrf2
activity.
2. Materials and methods
2.1. Antibodies and reagents
Anti-phospho-speciﬁc mTOR, mTOR, phospho-speciﬁc stress-
activated protein kinase/c-jun N-terminal kinase (SAPK/JNK),
SAPK/JNK, phospho-speciﬁc p38, p38, Myc (9B11) and Nrf2
antibodies were obtained from Cell Signaling Technology. Anti-
phospho-speciﬁc ERK and ERK antibodies were purchased from
Santa Cruz. Anti-LC3 antibody was obtained from MBL Medical &
Biological Laboratories. Anti-b-actin antibody was purchased from
Millipore. Myc-Nrf2 and GFP-LC3 plasmids were used previously
[28]. SFN was purchased from Calbiochem. U0126 was obtained
from Biomol. PD184352 was kindly provided by R. Marquez
(University of Dundee, UK). N-acetyl-L-cysteine (NAC), 6-carboxy-
20,70-dichlorodihydroﬂuorescien diacetate (DCF-DA), resazurin
and chloroquine were purchased from Sigma.
2.2. Cell culture
Immortalized mouse CN1.4 cortical neurons and human SH-
SY5Y neuronal cells were cultured in Dulbecco’s modiﬁed Eagle’s
medium (DMEM) supplemented with 10% fetal bovine serum
(FBS) and 10 units/ml penicillin and 100 units/ml streptomycin
in a humidiﬁed atmosphere containing 5% CO2. CN1.4 cortical neu-
rons and SH-SY5Y cells were maintained at 33 C and 37 C,
respectively.
2.3. Immunoblotting
Cells were washed once with PBS and lysed with modiﬁed RIPA
buffer (10 mM Tris–HCl [pH 7.4], 150 mM NaCl, 1 mM EGTA, 1%
NP-40, 0.25% sodium deoxycholate, 0.1% SDS) containing 1 mM
NaF, 1 mM Na3VO4, 1 mM PMSF and 10 lg/ml each of aprotinin,
leupeptin and pepstatin. Proteins were extracted on ice with peri-
odic vortexing for 30–40 min, and lysates were cleared by centrifu-
gation at 10000g for 10 min at 4 C, and the supernatants were
used for immunoblotting following boiling in 1 SDS-sample load-
ing buffer for 5 min. For analysis protein samples (40 lg) were sep-
arated on 4–12% gradient SDS–polyacrylamide gels (Invitrogen)followed by transfer to nitrocellulose membranes (GE Healthcare)
and immunoblotting with the indicated antibodies. Blots were
developed with chemiluminescence (GE Healthcare). All protein
concentrations were determined using the BCA method (Sigma).
2.4. Electron microscopy (EM)
Immortalized mouse CN1.4 cortical neurons were treated with
10 lM SFN for 24 h. Cells were ﬁxed overnight in a mixture of cold
2.5% glutaraldehyde in 0.1 M phosphate buffer (pH 7.2) and 2%
paraformaldehyde (PFA) in 0.1 M phosphate buffer (pH 7.2) and
embedded with epoxy resin. The epoxy resin-mixed samples were
loaded into capsules and polymerized at 60 C for 48 h. Thin sec-
tions were sliced on an ultramicrotome (UC7, Leica) and collected
on a copper grid. Appropriate areas for thin sectioning were cut at
70 nm and stained with saturated 2% uranyl acetate and 2% lead
citrate before examination on a transmission electron microscope
(Libra 120, Carl Zeiss) at 120 kV.
2.5. ROS measurement
Immortalized mouse CN1.4 cortical neurons were treated
with SFN for 8 h. Then, the cells were treated with 10 lM of 6-car-
boxy-20,70-dichlorodihydroﬂuorescien diacetate (DCF-DA, Sigma)
in culture media without serum for 30 min. The cells were washed
three times with PBS followed by ﬁxation with 4% PFA. The ﬂuores-
cence was observed using a ﬂuorescence microscope (Carl Ziess).
For the analysis of ﬂow cytometry, the cells were trypsinized and
resuspended in PBS. The intracellular ﬂuorescence was detected
at the channel for FITC (BD FACSVerse Instrument).
2.6. siRNA transfection
For knock-down of endogenous mouse Nrf2, mouse Nrf2 spe-
ciﬁc siRNA or scrambled RNA as a control was mixed with Oligofec-
tamine (Invitrogen) in serum-free Opti-MEM medium for 15 min.
The mixture was loaded onto CN1.4 cortical cells following
exchange of the culture medium for serum-free DMEM medium.
After 4 h, FBS was added up to 5% and maintained at 33 C in a
humidiﬁed atmosphere containing 5% CO2 for 36 h. The On-TAR-
GET plus smart pool mouse Nrf2 speciﬁc siRNA was purchased
from Thermo Scientiﬁc.
3. Results
3.1. SFN induces autophagy in neuronal cells
To examine whether SFN could induce autophagy in neuronal
cells, immortalized mouse CN1.4 cortical cells were treated with
SFN (10 lM) for 24 h. The level of LC3-II, a well-known marker of
autophagy, was analyzed. As shown in Fig. 1A and B, the level of
LC3-II in cells treated with SFN was signiﬁcantly increased com-
pared to control cells not treated. An increase in the number of
autophagic vesicles (AV) in the cells treated with SFN was also
observed (Figs. 1C–E and 2). The increase of LC3-II could be due
to an interruption in autophagosome–lysosome fusion, raising
the lysosomal pH or inhibiting lysosome-mediated proteolysis
[29]. To further clarify whether the increased level of LC3-II by
SFN treatment was caused by interrupting the autophagosome-
lysosome fusion or not, we treated neuronal cells with SFN fol-
lowed by treatment with chloroquine (CQ), a lysosomal inhibitor
for 6 h. Expectedly, LC3-II was accumulated in cells treated with
CQ, and the level of accumulated LC3-II was more increased in cells
treated with SFN along with CQ than those treated with SFN or CQ
alone (Fig. 3). Together, these results suggest that SFN induces
autophagy via increasing autophagic ﬂux in neuronal cells.
Fig. 1. SFN induces autophagy in neuronal cells. Mouse cortical cells (CN1.4) were treated with either DMSO (Veh) or 10 lM SFN for 24 h. (A) Cell lysates were analyzed by
immunoblotting using anti-pmTOR, mTOR, and LC3 antibodies, respectively. (B) Bar graph indicates the relative ratio of LC3-II to actin of triplicate experiments. (C, D) CN1.4
cells transiently transfected with the GFP-LC3 plasmid were treated with either DMSO (Veh) or 10 lM SFN for 24 h. (C) The cells were observed under ﬂuorescence
microscope. Arrows indicated autophagic vesicles (AVs). (D) Bar graph indicates the number of AVs per cell in about 15 cells randomly chosen. (E) Bar graph indicates
the number of AVs per cell in about 10 cells observed under transmission electron microscope (TEM). Data shown are mean ± S.E.M. of three independent experiments.
(⁄⁄, P < 0.01; ⁄⁄⁄, P < 0.001).
Fig. 2. SFN enhances the formation of autophagic vesicles. Mouse cortical neurons (CN1.4) were treated with either DMSO (Veh) or 10 lM SFN for 24 h. The cell images were
taken with transmission electron microscope (TEM). Dotted lines in left panel indicate the enlarged area for images on the right, respectively.
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Fig. 3. SFN increases autophagy ﬂux. Mouse cortical cells (CN1.4) were treated with
either DMSO (Veh) or 10 lM SFN for 18 h. To examine whether SFN increases
autophagy ﬂux, chloroquine (CQ, 50 lM), a lysosomal inhibitor, was added to the
cells, and incubated for an additional 6 h. (A) The levels of LC3 were investigated
with immunoblotting using anti-LC3 antibody (B) Bar graph indicates the relative
ratio of LC3-II to actin of triplicate experiments. Data shown are mean ± S.E.M. of
three independent experiments. (⁄, P < 0.05).
Fig. 4. ERK is activated during SFN-induced autophagy. (A) Mouse cortical cells (CN1.4
incubator during indicated time. Then, cell lysates were analyzed by immunoblotting usin
(B) The levels of LC3 were analyzed by immunoblotting using anti-LC3 antibody. (C) Ba
shown are mean ± S.E.M. of three independent experiments. (⁄, P < 0.05; ⁄⁄, P < 0.01; ⁄⁄⁄,
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To examine what kinds of signaling pathways are involved in
SFN-induced autophagy in neuronal cells, we ﬁrst analyzed the
level of phosphorylated mTOR (pmTOR), a key regulator in autoph-
agy [30], in CN1.4 cortical cells treated with SFN (10 lM). As
shown in Figs. 1A and 4A, there was no change in the level of
pmTOR in cells irrespective of SFN treatment, indicating that mTOR
signaling is likely not involved in SFN-induced autophagy.
The mitogen-activated protein kinases (MAPKs) such as ERK
and JNK have been found to be downstream mediators of ROS-
induced autophagy [31]. Thus, it is speculated that MAPKs acti-
vated by SFN treatment could induce autophagy in neuronal cells.
First, we examined the levels of phosphorylated ERK1/2 (pERK) in
cells treated with SFN (10 lM) at several time points (from 3 h to
2 days). Interestingly, increases in phosphorylated ERK1/2 were
observed at 3 h following SFN treatment and remained elevated
for up to 24 h. At 48 h phosphorylated ERK1/2 had returned to
basal levels (Fig. 4A). The level of LC3-II also started to increase fol-
lowing the activation of ERK at 3 h and kept by 48 h (Fig. 4B). In
addition, we investigated the activation of other mitogen-activated
protein kinases (MAPKs) such as p38 MAPK and JNK by immuno-
blotting using phospho-speciﬁc p38 MAPK and JNK antibodies,
respectively; however, activation of neither p38 MAPK (data not
shown) nor JNK (Fig. 4A) was observed, irrespective of SFN treat-
ment. Together, the results indicate that only ERK activation might
be involved in the SFN-induced autophagy.
To further examine the involvement of ERK signaling in
SFN-induced autophagy, we analyzed the levels of phosphorylated
ERK1/2 and LC3-II in neuronal cells treated with different concen-
trations of SFN. When neuronal cells were treated with different
concentrations of SFN (0–20 lM), both the levels of phosphory-
lated ERK1/2 and LC3-II started to increase signiﬁcantly at 5 lM
of SFN compared to untreated control cells (Fig. 5A and D). Inter-
estingly, both the increased levels of phosphorylated ERK1/2 and
LC3-II were in proportion to the concentration of SFN added,
indicating that SFN-induced autophagy is induced in a concentra-
tion-dependent manner together with ERK activation. In addition,
in SH-SY5Y cells, human neuroblastoma cells, SFN (10 lM) treat-
ment for 24 h increased levels of LC3-II together with increases) were treated with either DMSO (Veh) or 10 lM SFN. The cells were kept in CO2
g anti-pmTOR, mTOR, pERK, ERK, pSAPK/JNK and SAPK/JNK antibodies, respectively.
r graph indicates the relative ratio of LC3-II to actin of triplicate experiments. Data
P < 0.001).
Fig. 5. ERK activation is involved in SFN-induced autophagy. (A) Mouse cortical cells (CN1.4) were treated with different concentrations of SFN as indicated for 24 h. Cell
lysates were analyzed by immunoblotting using anti-pERK, ERK1/2, and LC3 antibodies, respectively. (B) SH-SY5Y cells were treated with 10 lM SFN for 24 h. Cell lysates
were analyzed by immunoblotting using anti-pERK, ERK1/2, and LC3 antibodies, respectively. (C) CN1.4 cortical neurons were pretreated with either DMSO (Veh) or MEK
speciﬁc inhibitors, 2 lM PD184352 and 5 lMU0126, and followed by SFN treatment for 24 h. Cell lysates were analyzed by immunoblotting using anti-pERK, ERK1/2, and LC3
antibodies, respectively. (D–F) Bar graph indicates the relative ratio of LC3-II to actin of triplicate experiments performed in A, B and C, respectively. Data shown are
mean ± S.E.M. of three independent experiments. (⁄, P < 0.05; ⁄⁄, P < 0.01; ⁄⁄⁄, P < 0.001).
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that ERK activation is involved in SFN-induced autophagy. Lastly,
to investigate whether SFN-mediated ERK activation is directly
related to the activation of autophagy, we used speciﬁc mitogen
protein kinase kinase (MEK) inhibitors, PD184352 and U0126 to
block the ERK signaling pathway. Neuronal cells were pretreated
with PD184352 (2 lM) and U0126 (5 lM) for 30 min before
SFN treatment. The MEK inhibitors completely blocked the
SFN-induced increase of LC3-II along with attenuation of ERK1/2
phosphorylation (Fig. 5C and F). Together, the results strongly sug-
gest that SFN-induced autophagy in neuronal cells is mediated by
ERK activation.
3.3. SFN-induced autophagy is mediated by reactive oxygen species
ROS are important inducers of autophagy [18–21]. Previously,
SFN has been known to induce antiproliferative responses as well
as cell death via ROS generation in epithelial or cancer cells
[22–24]. Thus, we examined whether SFN could generate ROS in
neuronal cells using DCF-DA. As expected, an increase of ROS
was observed in cells treated with SFN, compared to control cells
not treated (Fig. 6A–C). To examine if SFN-induced ROS affects
autophagy, we used NAC, a well-known antioxidant, to quench
ROS production. As shown in Fig. 6D and E, pretreatment with
10 mM NAC completely blocked both the increase of LC3-II and
the activation of ERK1/2 by SFN treatment. The results suggest that
ROS generated by SFN participates in the activation of autophagy
via ERK activation.3.4. Nrf2 activity is not involved in autophagy
SFN has been known to activate Nrf2, thus inducing the expres-
sion of phase II detoxifying enzymes such as glutathione transfer-
ase, HO-1 and NAD(P)H:quinine reductase [2,3]. As expected, ARE
activation in CN1.4 cortical neurons was signiﬁcantly increased
in a concentration-dependent fashion following SFN treatment or
co-transfection with a Nrf2 expression plasmid (Supplemental
Fig. 1A and B). Also, the dramatic induction of HO-1 was observed
in neuronal cells following SFN treatment (Supplemental Fig. 1C
and D). To examine whether the transcriptional activity of Nrf2 is
involved in the induction of autophagy, we examined the level of
LC3-II following ectopic expression of Nrf2. As shown in Fig. 7A
and B, there was no difference in the levels of LC3-II in cells
transiently transfected with the Nrf2 expression plasmid or not.
Moreover, the increase of LC3-II level in the cells treated with CQ
alone was not different from that in the cells transiently transfec-
ted with the Nrf2 expression plasmid. In addition, knockdown of
Nrf2 did not affect the level of LC3-II (Fig. 7C and D). Together,
the results suggest that Nrf2 activity is not involved in autophagy.
4. Discussion
Autophagy is a highly controlled process that can be induced by
a wide range of cellular stimuli and conditions such as metabolic
stress, ER stress, oxidative stress and hypoxia [32]. A growing num-
ber of studies show that autophagy is activated by elevated levels
of ROS elevated due to cellular stress conditions [18–21]. Thus,
Fig. 6. SFN increases the intracellular level of reactive oxygen species (ROS). (A) Mouse cortical neurons (CN1.4) were treated with either DMSO (Veh) or 10 or 20 lM SFN for
8 h. To examine the levels of ROS in the cells, 10 lM DCF-DA was incubated for 30 min, and then cellular ﬂuorescence in the cells treated with either DMSO (Veh) or 10 lM
SFN was observed under ﬂuorescence microscope. (B) Dot graph indicates the arbitrary intensities of cellular ﬂuorescence in about 20 cells randomly chosen. (C) The cells
were subjected to ﬂow cytometry analysis of DCF-DA. 10000 events were collected. (D) CN1.4 cells pretreated with 10 mMN-acetyl-L-cysteine (NAC) were treated with either
DMSO (Veh) or 10 lM SFN for 24 h. Cell lysates were analyzed by immunoblotting using anti-pERK, ERK1/2, and LC3 antibodies, respectively. (E) Bar graph indicates the
relative ratio of LC3-II to actin of triplicate experiments. Data shown are mean ± S.E.M. (⁄, P < 0.05; ⁄⁄⁄, P < 0.001).
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ROS-producing compartments and helps increase survival by
removing damaged proteins, lipids and dysfunctional organelles.
Previously, a study reported that SFN induces autophagy via ROS
production in cancer cells [25]; however, little is known about
the signaling pathway which is involved in the SFN-induced
autophagy, especially in neuronal cells. Here, we present for the
ﬁrst time in neuronal cells that SFN activates the ERK signaling
pathway via increased ROS, which results in enhanced autophagy.The ERK signaling pathway as a member of the mitogen-
activated protein kinase (MAPK) family has been known to be
involved in many aspects of cell biological functions such as prolif-
eration, migration, differentiation and death [33–35]. In brain, it
has been demonstrated that the ERK pathway is also activated in
response to growth factors, chemokines, oxidative stress and ische-
mic injury [36]. MAPKs such as ERK and JNK have been found to be
downstream effects of ROS in autophagy induction [31,37,38].
Here, we showed that SFN-induced ROS activates ERK and in turn
Fig. 7. Nrf2 activity is not involved in autophagy. (A) Mouse cortical cells (CN1.4) transiently transfected with mock or Myc-Nrf2 expression plasmid using the Lipofectamine
2000 (Invitrogen) were treated with 50 lM CQ for 12 h. Cell lysates were analyzed by immunoblotting using anti-Myc (9B11) and LC3 antibodies, respectively. (B) Bar graph
indicates the relative ratio of LC3-II to actin of triplicate experiments. (C) CN1.4 cells were transfected with siRNA speciﬁc Nrf2 or scrambled siRNA as a control using the
Oligofectamine (Invitrogen) and kept for 36 h. Cell lysates were analyzed by immunoblotting using anti-Nrf2 and LC3 antibodies, respectively. (D) Bar graph indicates the
relative ratio of LC3-II to actin of triplicate experiments. Data shown are mean ± S.E.M. of three independent experiments.
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increase the activation of the MAPKs, JNK and p38 MAPK
(Fig. 4A). Thus, our results suggest that SFN-induced ERK activation
is sufﬁcient for the activation of autophagy in neuronal cells.
SFN has been well known as a potent inducer of the phase II
antioxidant enzymes including HO-1 [2,3]. Treatment of mouse
cortical cells with SFN resulted in a signiﬁcant induction of HO-1
together with an increase in ARE reporter activity (Supplemental
Fig. 1A, C and D), indicating that SFN strongly activates Nrf2 tran-
scriptional activity in neuronal cells. Also, ectopic expression of
Nrf2 in cortical neuronal cells resulted in a dramatic increase
(about 16-fold) of ARE promoter activity (Supplemental Fig. 1B);
however, it did not affect the levels of LC3-II (Fig. 7A and B), indi-
cating that Nrf2 activity itself might be not involved in autophagy
induction. Previously, the expression of p62/SQSTM1, an autoph-
agy receptor, was reported to be dependent on Nrf2 activity [39].
Thus, it is likely that Nrf2 activity is required for the induction of
p62, but not for autophagy itself.
There are data indicating that ROS modiﬁes cysteine residues of
DUSP1 or Raf1, which activates ERK [35]. A recent study described
that autophagosomes function as cellular scaffolds in the activa-
tion of ERK [39]. Thus, SFN-induced autophagy might help ERK
activation to be enhanced or to be sustained for a longer time
(Fig. 4). Also, it was reported that ERK can accelerate the transcrip-
tional activity of Nrf2 through stimulating its translocation into
nucleus by direct phosphorylation [40,41]. Thus, it is speculated
that SFN generates ROS (Fig. 6), which could activate both ERK
and Nrf2. In turn, activated ERK helps Nrf2 to translocate intonucleus, thus protecting neuronal cells from ROS-mediated cellular
damages. Thus, it is likely that SFN-mediated ERK activation plays
a dual role in neuronal survival through the induction of autophagy
as well as the stimulation of Nrf2 activity.
SFN has been suggested as a potential protective phytochemical
against neurodegenerative diseases [42]. SFN could be used for
evoking acute changes in the expression of Nrf2-dependent genes
in brain by simple intraperitoneal (IP) injection, because SFN can
pass through the blood brain barrier (BBB). Thus, its biological pro-
tective activity in several brain injury models has been estimated
following IP injection: SFN treatment showed neuroprotective
effects, improved cognitive function and suppressed the produc-
tion of inﬂammatory cytokines such as IL-6 and TNF-a in several
brain injury models [10,43,44]. In case of direct administration of
SFN ameliorated cognitive function of Ab-induced acute AD mouse
models, indicating that SFN is useful in the protection from amy-
loidgenic damages [45]. Until now, the biological activity of SFN
in brain has been presumed to be originated from the protective
activity of detoxifying enzymes induced by SFN. Our result
provides a possibility that SFN-induced autophagy might play a
therapeutic function in brain.
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